| Literature DB >> 27708367 |
Xu-Fu Zhang1, Yan Long1, Ming Tan2,3, Ting Zhang4, Qiong Huang5, Xi Jiang2,3, Wen-Fang Tan1, Jian-Dong Li4, Gui-Fang Hu4, Shixing Tang4, Ying-Chun Dai4.
Abstract
Rotaviruses are known to recognize human histo-blood group antigens (HBGAs) as a host ligand that is believed to play an important role in rotavirus host susceptibility and host range. In this study, paired fecal and saliva samples collected from children with viral gastroenteritis, as well as paired serum and saliva samples collected from the general population in south China were studied to evaluate potential association between rotavirus infections and human HBGA phenotypes. Rotavirus was detected in 75 (28%) of 266 fecal samples and P[8] rotaviruses were found to be the predominant genotype. The HBGA phenotypes of the rotavirus-infected children were determined through their saliva samples. Secretor statuses were found to correlate with the risk of rotavirus infection and all P[8]/P[4] rotavirus infected children were secretors. Accordingly, recombinant VP8* proteins of the P[8]/P[4] rotaviruses bound saliva samples from secretor individuals. Furthermore, correlation between serum P[8]/P[4]-specific IgG and host Lewis and secretor phenotypes has been found among 206 studied serum samples. Our study supported the association between rotavirus infection and the host HBGA phenotypes, which would help further understanding of rotavirus host range and epidemiology.Entities:
Mesh:
Year: 2016 PMID: 27708367 PMCID: PMC5052604 DOI: 10.1038/srep34591
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The A/B/H and Lewis antigen profiles of the saliva samples from children who was infected with P[8] (A) or P[4] (B) rotavirus infection. The histo-blood group antigen (HBGA) profiles of the ten nonsecretors were shown in (C).The numbered saliva samples are indicated in the X-axis. Different HBGAs are shown in various colors as indicated.
Associations and Influence of A/B/O, Lewis, and secretor blood types among children with the risk of rotavirus infection.
| Status | No. (%) of RV positive | No. (%) of RV/NoV† negative | OR (95% CI), | No. (%) of health control | OR (95% CI), |
|---|---|---|---|---|---|
| Blood type | n = 75 | n = 151 | n = 159 | ||
| A | 22 (29.3) | 47 (31.1) | 35 (22.0) | ||
| B | 17 (22.7) | 44 (29.1) | 39 (24.5) | ||
| O | 33 (44.0) | 50 (33.1) | 79 (49.7) | ||
| AB | 3 (4.0) | 10 (6.6) | 6 (3.8) | ||
| Lewis status | n = 75 | n = 151 | n = 159 | ||
| Leb+/Ley+ | 63 (84.0) | 132 (87.4) | 134 (84.3) | ||
| Lea+/Lex+ | 0 (0.0) | 10 (5.6) | 20 (12.6) | ||
| Lea+b+/Lex+y+ | 12 (16.0) | 9 (6.0) | 5 (3.1) | ||
| Secretor status§ | n = 75 | n = 151 | n = 159 | ||
| Secretor | 75 (100) | 141 (93.4) | 139 (87.4) | ||
| Nonsecretor | 0 (0) | 10 (6.6) | 20 (12.6) |
†NoV samples were excluded from patients without RV infection; Unadjusted odds ratios (OR) and 95% confidence intervals (CIs); §Leb+/Ley+ and Lea+b+/Lex+y+ were grouped into secretor and Lea+/Lex+ were grouped into nonsecretor; P: significance test of proportion of different HBGA phenotype between RV positive group and control group; *P < 0.05; **P < 0.01.
Figure 2Production of the GST-VP8* fusion proteins and their saliva-based HBGA bindings.
(A) Analysis of the GST-VP8* fusion proteins of P[8] and P[4] rotaviruses by SDS-PAGE with bovine serum albumin (BSA) as standards on the same gels for protein quantitation. Lane 1–3: elution fraction 1 to 3 of the GST-VP8* fusion protein of P[8] rotavirus; lane 4: elution 1 of the GST-VP8* fusion protein of P[4] rotavirus; lane 5–8: BSA standard protein at amounts of 8, 4, 2, 1 μg, respectively; lane 9: VP8* protein of P[8] rotavirus; lane 10: VP8* protein of P[4] rotavirus; lane 11–12: GST elution; lane 13–16: BSA standard protein at amounts of 4, 3, 2, 1 μg, respectively; M: protein marker. (B,C) Eight boiled saliva samples were coated onto 96-well plates and then incubated with the GST-VP8* fusion proteins of P[8] (B) or P[4] (C) rotavirus. The protein was tested in a series of 3-fold dilutions (15 μg/ml, 5μg/ml and 1.7 μg/ml) by enzyme-linked immunosorbent assay (ELISA). (D–G) The binding activities of the GST-VP8* fusion proteins of P[8] (D,E) or P[4] (F,G) rotavirus at 10 μg/ml to 85 saliva samples, among which 75 were from individuals with confirmed rotavirus infection, while 10 were from non-secretor individuals without rotavirus infection. The saliva samples were sorted by blood types (D,F), or by the Leb signals of individual saliva samples (E,G). “A,” “B,” “O,” and “N” represent the type A, B, O and non-secretor saliva, respectively.
Association between rotavirus IgG antibodies and the A/B/O, Lewis and secretor bloodtypes.
| Status | P[8] | P value | P[4] | P value | ||
|---|---|---|---|---|---|---|
| No. (%) of positive | No. (%) of negative | No. (%) of positive | No. (%) of negative | |||
| Blood type | 142 | 64 | 0.677 | 134 | 72 | 0.157 |
| A | 31 (21.8) | 16 (25.0) | 31 (23.1) | 16 (22.2) | ||
| B | 32 (22.5) | 11 (17.2) | 33 (24.6) | 10 (13.9) | ||
| O | 74 (52.1) | 36 (56.2) | 65 (48.5) | 45 (62.5) | ||
| AB | 5 (3.5) | 1 (1.6) | 5 (3.7) | 1 (1.4) | ||
| Lewis status | 142 | 64 | 0.001** | 134 | 72 | 0.000** |
| Leb+/Ley+ | 118 (83.1) | 38 (59.4) | 114 (85.1) | 42 (58.3) | ||
| Lea+/Lex+ | 14 (9.9) | 14 (21.9) | 11 (8.2) | 17 (23.6) | ||
| Lea+b+/Lex+y+ | 10 (7.0) | 12 (18.8) | 9 (6.7) | 13 (18.1) | ||
| Secretor status§ | 142 | 64 | 0.027* | 134 | 72 | 0.005** |
| Secretor | 128 (90.2) | 50 (78.1) | 123 (91.8) | 55 (76.4) | ||
| Nonsecretor | 14 (9.8) | 14 (21.9) | 11 (8.2) | 17 (23.6) | ||
§Leb+/Ley+ and Lea+b+/Lex+y+ were grouped into secretor and Lea+/Lex+ were grouped into nonsecretor; *P < 0.05; **P < 0.01.
Figure 3The geometric means of P[8]/P[4] rotavirus VP8-specific antibody titers (Y-axis) in the secretor (S) and non-secretor (N) individuals.
The error bars shows standard error. **P < 0.001.